发明名称 Benzofuro[3,2-<i>c</i>] pyridines and related analogs as serotonin sub-type 6 (5-HT<sub>6</sub>) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
摘要 The present invention relates to benzofuro[3,2-c]pyridine and azepine analogs as serotonin sub-type 6 (5-HT6) modulators, pharmaceutical compositions including these compounds, methods of preparation, and use thereof. These compounds are useful in the treatment of central nervous system disorders including obesity, metabolic syndrome, cognition, schizophrenia, attention deficit hyperactivity disorder, bipolar disorder, rare and orphan diseases, and sleep disorders. The subject compounds have the structure of formula (I); with the substituents being described herein.
申请公布号 US9067949(B2) 申请公布日期 2015.06.30
申请号 US201213352864 申请日期 2012.01.18
申请人 Albany Molecular Research, Inc. 发明人 Guzzo Peter R.;Henderson Alan J.;Isherwood Matthew;Lee Chong Yew;Ghosh Animesh;Zhao He
分类号 C07D491/048;C07D307/91;C07D491/18;C07D491/08 主分类号 C07D491/048
代理机构 LeClairRyan, a Professional Corporation 代理人 LeClairRyan, a Professional Corporation
主权项 1. A compound of formula (I):wherein: G is —(CR5R6)n—, where n=1,2 Z is —(CR10R11)m—, where m=1,2 P is N—R7 or CR21—OR22 R1 and R4 are independently H, halogen, CF3, CHF2, CH2F, OH, OR15, —C(O)R15, —C(O)OR15, —C(O)NR15R16, —NHR15, —NR15R16, —SR15, —S(O)R15, —S(O)2R15, NH2, CN, NO2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, mono or polycyclic aryl, or mono or polycyclic heteroaryl containing from 1 to 5 heteroatoms selected from the group consisting of nitrogen, sulfur, and oxygen, each R1 or R4 optionally substituted from 1 to 3 times with substituents selected from the group consisting of halogen, OH, OR17, —C(O)R17, —C(O)OR17, —C(O)NR17R18, —NHR17, —NR17R18, —SR17, —S(O)R17, —S(O)2R17, NH2, CN, NO2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, mono or polycyclic aryl, and mono or polycyclic heteroaryl containing from 1 to 5 heteroatoms selected from the group consisting of nitrogen, sulfur, and oxygen; R2 and R3 are independently H, R14S(O)2—, or R14S(O)—; R5, R6, R10, and R11 are independently H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 alkoxy, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, aryl C1-C6 alkyl, mono or polycyclic aryl, or mono or polycyclic heteroaryl containing from 1 to 5 heteroatoms selected from the group consisting of nitrogen, sulfur, and oxygen, each R5, R6, R10, or R11 optionally substituted from 1 to 3 times with substituents selected from the group consisting of halogen, OH, OR17, —C(O)R17, —C(O)OR17, —C(O)OR17R18, —NHR17, —NR17R18, —SR17, —S(O)R17, —S(O)2R17, NH2, CN, NO2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, mono or polycyclic aryl, and mono or polycyclic heteroaryl containing from 1 to 5 heteroatoms selected from the group consisting of nitrogen, sulfur, and oxygen; or R6 and R10 can combine to form a —(CH2)n—, wherein n represents an integer from 2 to 3; R7 is independently H, OH, OR15, —C(O)R15, —C(O)OR15, —C(O)NR15R16, —S(O)R15, —S(O)2R15, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, aryl C1-C6 alkyl, mono or polycyclic aryl, or mono or polycyclic heteroaryl containing from 1 to 5 heteroatoms selected from the group consisting of nitrogen, sulfur, and oxygen, each R7 optionally substituted from 1 to 3 times with substituents selected from the group consisting of halogen, OH, NH2, CN, NO2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, mono or polycyclic aryl, and mono or polycyclic heteroaryl containing from 1 to 5 heteroatoms selected from the group consisting of nitrogen, sulfur, and oxygen; R12 and R13 are independently H, halogen, CF3, CHF2, CH2F, OH, OR15, —C(O)R15, —C(O)OR15, —C(O)NR15R16, —NHR15, —NR15R16, —SR15, —S(O)R15, —S(O)2R15, NH2, CN, NO2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, mono or polycyclic aryl, or mono or polycyclic heteroaryl containing from 1 to 5 heteroatoms selected from the group consisting of nitrogen, sulfur, and oxygen, each R12 or R13 optionally substituted from 1 to 3 times with substituents selected from the group consisting of halogen, OH, NH2, CN, NO2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, mono or polycyclic aryl, and mono or polycyclic heteroaryl containing from 1 to 5 heteroatoms selected from the group consisting of nitrogen, sulfur, and oxygen; or R14 is independently a substituted or unsubstituted mono or polycyclic aryl or substituted or unsubstituted mono or polycyclic heteroaryl containing from 1 to 5 heteroatoms selected from the group consisting of oxygen, nitrogen, and sulfur, each R14 optionally substituted from 1 to 4 times for each cyclic ring with substituents selected from the group consisting of H, OH, OR15, —C(O)R15, —C(O)OR15, —C(O)NR15R16, —NHR15, —NR15R16, —SR15, —S(O)R15, —S(O)2R15, NH2, CN, NO2, halogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, mono or polycyclic aryl, and mono or polycyclic heteroaryl containing from 1 to 5 heteroatoms selected from the group consisting of nitrogen, sulfur, and oxygen, each one of the R14 substituents further optionally substituted from 1 to 3 times with substituents selected from the group consisting of halogen, H, OH, OR17, —C(O)R17, —C(O)OR17, —C(O)NR17R18, —NHR17, —NR17R18, —SR17, —S(O)R17, —S(O)2R17, NH2, CN, NO2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, mono or polycyclic aryl, and mono or polycyclic heteroaryl containing from 1 to 5 heteroatoms selected from the group consisting of nitrogen, sulfur, and oxygen; R15, R16, R17, and R18 are independently H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, a monocyclic aryl or a monocyclic heteroaryl containing from 1-5 heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur, each R15, R16, R17, or R18 optionally substituted from 1 to 3 times with substituents selected from the group consisting of halogen, OH, CN, NO2, NH2, H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, and a monocyclic aryl; or R15 and R16 or R17 and R18 can combine to form a 3- to 7-membered heterocyclyl or a mono heteroaryl each containing from 1 to 5 heteroatoms selected from the group consisting of nitrogen, sulfur, and oxygen, wherein the heterocyclyl or heteroaryl are optionally substituted from 1 to 3 times with substituents selected from the group consisting of halogen, OH, CN, NO2, NH2, H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, a monocyclic aryl, and monocyclic heteroaryl; R21 and R22 are independently H or C1-C6 alkyl;with the provisos that (a) when n=2, m=1 (b) at least one of R2 and R3, but not both, is H;or an oxide thereof, a pharmaceutically acceptable salt thereof, or a solvate thereof.
地址 Albany NY US